Last reviewed · How we verify

NCT05799508

Consequences of COVID-19 Infection for Child Health and Wellbeing: Protocol for a Prospective, Observational, Longitudinal Study in Children

Status unknown Last updated 5 April 2023
What this trial tests

trial in Long COVID in 1,200 participants. Status unknown.

Timeline
1 January 2021
Primary endpoint
31 December 2022
31 December 2024

Quick facts

Lead sponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,200
Start date1 January 2021
Primary completion31 December 2022
Estimated completion31 December 2024
Sites1 location across Italy

Conditions studied

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Who can join

Adults 4 Weeks to 18, any sex, with Long COVID. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective follow-up of children with SARS-CoV-2

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Long COVID

Currently open trials in the same condition.

Other Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05799508.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing